These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34822925)

  • 1. Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors.
    Wang S; Zheng J; Ma L; Petersen RB; Xu L; Huang K
    Biochim Biophys Acta Gen Subj; 2022 Feb; 1866(2):130061. PubMed ID: 34822925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-polyphenolic natural inhibitors of amyloid aggregation.
    Ma L; Yang C; Zheng J; Chen Y; Xiao Y; Huang K
    Eur J Med Chem; 2020 Apr; 192():112197. PubMed ID: 32172082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
    Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
    Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
    Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
    Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.
    Khan MV; Zakariya SM; Khan RH
    Int J Biol Macromol; 2018 Jun; 112():217-229. PubMed ID: 29374532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-Like Protein Aggregates and Type 2 Diabetes.
    Mukherjee A; Soto C
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein misfolding and aggregation by natural phenolic compounds.
    Dhouafli Z; Cuanalo-Contreras K; Hayouni EA; Mays CE; Soto C; Moreno-Gonzalez I
    Cell Mol Life Sci; 2018 Oct; 75(19):3521-3538. PubMed ID: 30030591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling protein aggregation as an ageing related process or a neuropathological response.
    Trigo D; Nadais A; da Cruz E Silva OAB
    Ageing Res Rev; 2019 May; 51():67-77. PubMed ID: 30763619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lys-Specific Molecular Tweezer, CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity.
    Herzog G; Shmueli MD; Levy L; Engel L; Gazit E; Klärner FG; Schrader T; Bitan G; Segal D
    Biochemistry; 2015 Jun; 54(24):3729-38. PubMed ID: 26030124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease.
    Hipp MS; Hartl FU
    J Mol Biol; 2024 Jul; 436(14):168615. PubMed ID: 38759929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid aptamers for neurodegenerative diseases.
    Bouvier-Müller A; Ducongé F
    Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.
    Kumar S; Thangakani AM; Nagarajan R; Singh SK; Velmurugan D; Gromiha MM
    Sci Rep; 2016 Feb; 6():22258. PubMed ID: 26924748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental factors modulating protein conformations and their role in protein aggregation diseases.
    Devi S; Chaturvedi M; Fatima S; Priya S
    Toxicology; 2022 Jan; 465():153049. PubMed ID: 34818560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of protein homeostasis and aggregation.
    Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
    J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
    Ries HM; Nussbaum-Krammer C
    Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.